The Nationwide Medical Products Administration will not be liable for regulating pharmaceutical ingredients manufactured and exported by chemical providers. This regulatory deficiency, which has resulted in substantial Worldwide news coverage unfavorable to China, is noted for ten years, but failure of Chinese regulatory companies to cooperate has